Effect of L Carnitine on severity of uremic restless legs syndrome

Phase 2

Recruiting

• Conditions: Restless leg syndrome.; Restless legs syndrome; G25.81

• Registration Number: IRCT20130812014333N171
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 12 July 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 82

Inclusion Criteria

Dialysis patients with restless legs syndrome
Patient informed consent

Exclusion Criteria

Patients diagnosed with anxiety disorders
Patients with a diagnosis of sleep disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of Restless Legs Syndrome. Timepoint: Beginning of treatment, sixth week and end of treatment (three months later). Method of measurement: Based on clinical observation, physician and patient opinion.